DGAP-News

Wacker Chemie AG: WACKER ENDS Q3 2016 WITH GOOD RESULTS - Seite 3

17,136 employees (June 30, 2016: 17,081). As of the end of the reporting
quarter, WACKER had 12,179 employees in Germany (June 30, 2016: 12,230) and
4,957 at its international sites (June 30, 2016: 4,851).

Business Divisions
In Q3 2016, WACKER SILICONES posted total sales of EUR503.1 million, on a
par with the year-earlier level (EUR501.9 million). While volumes were
somewhat higher than a year ago, prices for a number of product groups
edged lower. Negative exchange-rate effects also decreased sales
marginally. The division's sales were some 2 percent below the preceding
quarter (EUR514.4 million) due to price and volume effects. EBITDA at
WACKER SILICONES reached EUR100.7 million in the reporting quarter, around
23 percent higher than a year ago (EUR81.6 million). Compared with the
preceding quarter (EUR93.7 million), it was up 8 percent. Earnings were
lifted by high plant utilization - over 90 percent on average - and by low
costs. The EBITDA margin improved to 20.0 percent in Q3 2016, after 16.3
percent a year ago and 18.2 percent in the preceding quarter.

At WACKER POLYMERS, total sales of EUR308.2 million in the reporting
quarter were 2 percent lower than a year ago (EUR313.0 million) and 5
percent below the preceding quarter (EUR325.7 million). Noticeably higher
dispersion volumes year over year did not fully compensate for somewhat
lower prices in a number of product groups. Negative exchange-rate effects,
too, weighed slightly on the sales trend. Compared with Q2 2016, average
prices were virtually unchanged, while volumes were lower on balance. The
division's EBITDA grew to EUR73.2 million in the reporting quarter,
compared with EUR64.7 million a year earlier - up 13 percent. This gain was
essentially due to the low cost level, which in turn benefited from high
plant utilization of almost 90 percent. Relative to the preceding quarter
(EUR78.2 million), EBITDA decreased by around 6 percent. The decline
stemmed not only from lower sales, but also from a quarter-over-quarter
increase in the price of ethylene, a base material. The EBITDA margin came
in at 23.8 percent in the reporting quarter, after 20.7 percent last year
and 24.0 percent in the preceding quarter.

WACKER BIOSOLUTIONS generated total sales of EUR54.0 million from July
through September 2016. That was 7 percent more than a year ago (EUR50.4
million) and 2 percent more than in Q2 2016 (EUR53.2 million). Higher
volumes in a number of segments were the main growth driver. On the other
hand, sales were slowed by a slight decline in prices for some products,